The safety of intravenous dipyridamole thallium myocardial perfusion imaging. Intravenous Dipyridamole Thallium Imaging Study Group
about
Metals in urine and peripheral arterial disease.New directions in myocardial perfusion imaging.Dipyridamole echocardiography.Evaluating coronary artery disease noninvasively--which test for whom?Stress testing in the elderly.Pharmacologic radionuclide myocardial perfusion imaging.Procedure guidelines for radionuclide myocardial perfusion imaging.Perioperative care of the vascular surgery patient: the perspective of the internist.Overview of exercise stress testing.Advances in pharmacologic agents in imaging: new A2A receptor agonists.Respiratory arrest during dipyridamole stress testing.Regadenoson in the detection of coronary artery disease.Regadenoson in Europe: first-year experience of regadenoson stress combined with submaximal exercise in patients undergoing myocardial perfusion scintigraphy.A Safety Evaluation of Cangrelor in Patients Undergoing PCI.Feasibility, safety and accuracy of regadenoson-atropine (REGAT) stress echocardiography for the diagnosis of coronary artery disease: an angiographic correlative study.Digital high frame rate stress echocardiography for detection of coronary artery stenosis by high dose dipyridamole stress testing.Unstable angina: prognosis, noninvasive risk assessment, and strategies for management.Pharmacologic stress testing: mechanism of action, hemodynamic responses, and results in detection of coronary artery disease.Do we still need dipyridamole?Association of ventricular ectopy with nuclear scintigraphic perfusion defects during dipyridamole stress testing.Lack of impact of myocardial ischemia on the signal-averaged ECG assessment by time-domain analysis.Experience of low-dose aminophylline use to relieve minor adverse effects of dipyridamole in patients undergoing stress myocardial perfusion imaging.Hypersensitivity of pulmonary C fibers induced by adenosine in anesthetized rats.Hemodynamic response, arrhythmic risk, and overall safety of regadenoson as a pharmacologic stress agent for myocardial perfusion imaging in chronic obstructive pulmonary disease and bronchial asthma patients.Acute myocardial infarction during regadenoson myocardial perfusion imaging.Feasibility, symptoms, adverse effects, and complications associated with noninvasive assessment of coronary flow velocity reserve in women with suspected or known coronary artery disease.Vasodilator stress agents for myocardial perfusion imaging.Activation of pulmonary C fibres by adenosine in anaesthetized rats: role of adenosine A1 receptors.Safety of adenosine pharmacologic stress myocardial perfusion imaging in orthotopic cardiac transplant recipients: a single center experience of 102 transplant patients.
P2860
Q24814162-3E144542-048E-4580-AE4D-785BBA2F3C39Q30467515-88E18117-636C-4BC9-BB31-661346DFB0F7Q33565116-D69BF077-494F-4E58-8870-65245EBF0D3FQ33607917-5F093A4C-49EE-4EAA-8414-44F378B2B398Q34422214-45039CE0-7E99-4615-8919-FA0B073A3115Q35031075-4F472195-F0E8-4567-817D-48DC913BF585Q35808137-2BCFE923-306C-497C-B696-4FD3E1C1F97EQ35918517-A92B45AF-73E5-4639-BCAA-6CA87FCE8FC8Q36415659-07584EE4-61B3-4D84-8DB5-274CC1ADF4E5Q36416508-18D79443-6C8F-4D40-8ADA-E9AC7514B062Q36727836-373FD279-AA68-420E-9158-90A0E795CEB9Q36812777-7FD70DCA-BC83-404A-8211-2508EEE14911Q37554933-6D3D9E07-1315-47EF-9145-0E24D728A5CEQ38672923-0443F3F4-8D82-463F-8151-35403A5F030AQ39264143-B19861B1-61D6-4B31-A134-9B40EF5ED768Q39369592-ABCD5B0A-C899-4525-B52C-CAD788ED2F0FQ40657398-887E1F29-DF51-4134-A6C2-D84500E755DFQ41675614-91461DE7-5AF5-4EB3-BCE4-46C18E2D61BBQ41760001-B60EF72E-DD57-43DC-AEDB-8072C262DFBFQ42544669-CF646B75-7933-4E30-BD6D-F50291F9CF3CQ44093944-AEFBA3BD-D042-40F4-BB35-3B3AB843C85AQ44416593-61090938-D0D9-420A-9016-940AF08A5DADQ44445799-FD019F6B-775C-4934-9F37-282DF1E7AC4AQ44704119-4339B82F-EB7A-452D-904E-C8F9131EDC43Q46986484-A7ED22F4-4781-401E-A809-A14D7D1D4D5EQ47676804-C85E310E-922A-482D-9A35-929E45D80311Q48065022-8291BAD5-2871-4DBF-A733-F437FEE59FC5Q51517531-8932AFBC-A669-4D53-927E-802E3E6E00DCQ53260243-472465EF-C450-4B02-97CA-73032D1267FA
P2860
The safety of intravenous dipyridamole thallium myocardial perfusion imaging. Intravenous Dipyridamole Thallium Imaging Study Group
description
1990 nî lūn-bûn
@nan
1990 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
The safety of intravenous dipy ...... e Thallium Imaging Study Group
@ast
The safety of intravenous dipy ...... e Thallium Imaging Study Group
@en
The safety of intravenous dipy ...... e Thallium Imaging Study Group
@nl
type
label
The safety of intravenous dipy ...... e Thallium Imaging Study Group
@ast
The safety of intravenous dipy ...... e Thallium Imaging Study Group
@en
The safety of intravenous dipy ...... e Thallium Imaging Study Group
@nl
prefLabel
The safety of intravenous dipy ...... e Thallium Imaging Study Group
@ast
The safety of intravenous dipy ...... e Thallium Imaging Study Group
@en
The safety of intravenous dipy ...... e Thallium Imaging Study Group
@nl
P356
P1433
P1476
The safety of intravenous dipy ...... e Thallium Imaging Study Group
@en
P2093
A Ranhosky
J Kempthorne-Rawson
P304
P356
10.1161/01.CIR.81.4.1205
P407
P577
1990-04-01T00:00:00Z